Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.

Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF, He YQ, Liu YJ, Chen JD, Li LH.

JAMA. 2008 Jan 9;299(2):185-93. doi: 10.1001/jama.2007.56-b.

PMID:
18182600
2.

Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.

Praharaj SK, Jana AK, Goyal N, Sinha VK.

Br J Clin Pharmacol. 2011 Mar;71(3):377-82. doi: 10.1111/j.1365-2125.2010.03783.x. Review.

3.

Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Ellinger LK, Ipema HJ, Stachnik JM.

Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Review.

PMID:
20233913
4.

Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Maayan L, Vakhrusheva J, Correll CU.

Neuropsychopharmacology. 2010 Jun;35(7):1520-30. doi: 10.1038/npp.2010.21. Review.

5.

Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.

Newall H, Myles N, Ward PB, Samaras K, Shiers D, Curtis J.

Int Clin Psychopharmacol. 2012 Mar;27(2):69-75. doi: 10.1097/YIC.0b013e32834d0a5b. Review.

PMID:
21979790
6.

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.

Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ.

Hum Reprod Update. 2015 Sep-Oct;21(5):560-74. doi: 10.1093/humupd/dmv025. Review.

PMID:
26060208
7.

Management of atypical antipsychotic drug-induced weight gain: focus on metformin.

Miller LJ.

Pharmacotherapy. 2009 Jun;29(6):725-35. doi: 10.1592/phco.29.6.725. Review.

PMID:
19476423
8.

Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.

Björkhem-Bergman L, Asplund AB, Lindh JD.

J Psychopharmacol. 2011 Mar;25(3):299-305. doi: 10.1177/0269881109353461. Review.

PMID:
20080925
9.

Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.

Mizuno Y, Suzuki T, Nakagawa A, Yoshida K, Mimura M, Fleischhacker WW, Uchida H.

Schizophr Bull. 2014 Nov;40(6):1385-403. doi: 10.1093/schbul/sbu030. Review.

10.

The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.

Khan AY, Macaluso M, McHale RJ, Dahmen MM, Girrens K, Ali F.

J Psychiatr Pract. 2010 Sep;16(5):289-96. doi: 10.1097/01.pra.0000388624.91039.a3. Review.

PMID:
20859106
11.

Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.

Hasnain M, Fredrickson SK, Vieweg WV.

J Psychopharmacol. 2011 Jun;25(6):715-21. doi: 10.1177/0269881110389214. Review.

PMID:
21169390
12.
13.

A systematic review of metformin to limit weight-gain with atypical antipsychotics.

Lee YJ, Jeong JH.

J Clin Pharm Ther. 2011 Oct;36(5):537-45. doi: 10.1111/j.1365-2710.2011.01255.x. Review.

PMID:
21418264
14.

Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis.

Liu Z, Zheng W, Gao S, Qin Z, Li G, Ning Y.

Shanghai Arch Psychiatry. 2015 Dec 25;27(6):331-40. doi: 10.11919/j.issn.1002-0829.215071. Review.

15.

The effect of antiobesity drugs on waist circumference: a mixed treatment comparison.

Chilton M, Dunkley A, Carter P, Davies MJ, Khunti K, Gray LJ.

Diabetes Obes Metab. 2014 Mar;16(3):237-47. doi: 10.1111/dom.12198. Review.

PMID:
23964810
16.

Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications.

Faulkner G, Cohn TA.

Can J Psychiatry. 2006 Jul;51(8):502-11. Review. Erratum in: Can J Psychiatry. 2006 Aug;51(9):620.

PMID:
16933587
17.

Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications.

Tek C, Kucukgoncu S, Guloksuz S, Woods SW, Srihari VH, Annamalai A.

Early Interv Psychiatry. 2016 Jun;10(3):193-202. doi: 10.1111/eip.12251. Review.

PMID:
25962699
18.

An overview of obesity in children with psychiatric disorders taking atypical antipsychotics.

Shin L, Bregman H, Frazier J, Noyes N.

Harv Rev Psychiatry. 2008;16(2):69-79. doi: 10.1080/10673220802073915. Review.

PMID:
18415880
19.

Avoiding weight gain in cardiometabolic disease: a systematic review.

Maruthur NM, Gudzune K, Hutfless S, Fawole OA, Wilson RF, Lau BD, Anderson CA, Bleich SN, Segal J.

J Obes. 2014;2014:358919. doi: 10.1155/2014/358919. Review.

20.

Evaluation of Internet-Based Interventions on Waist Circumference Reduction: A Meta-Analysis.

Seo DC, Niu J.

J Med Internet Res. 2015 Jul 21;17(7):e181. doi: 10.2196/jmir.3921. Review.

Items per page

Supplemental Content

Support Center